“Provides ~480 mg silymarin / ~180 mg silybin per serving”
The label discloses the standardized silymarin and silybin content per 2-softgel serving, and standardization to specific silybin isomers backs the number.
If your goal is to hit a trial-level silymarin dose without swallowing four capsules, this is the formula. One two-softgel serving delivers roughly 480 mg of standardized silymarin (~180 mg silybin) and stacks a 160 mg Siliphos phytosome fraction on top, so you get both dose and an absorption hedge in the same serving. The catches are soy content and top-of-set per-serving price.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Milk Thistle (Silymarin) guide →A hybrid: high-dose standardized extract plus a 160 mg Siliphos silybin-phytosome fraction. You get the absorption hedge of a phytosome layered onto a genuinely large silymarin load — close to the top of the category on form.
At ~480 mg silymarin / ~180 mg silybin per 2-softgel serving, this is the highest disclosed load in the set and lands squarely in the range used in clinical trials — the best score on this axis.
NSF-registered GMP facility with a Certificate of Analysis available. Strong, well-documented QC — a notch below Thorne's certification reputation but clearly above the budget field.
The priciest-per-serving of the standardized options, and a two-softgel serving. The dose and dual-delivery justify it, but on pure cost-per-serving it trails the value picks.
The softgel and phospholipid contain soy, which rules it out for soy-avoiders. Otherwise well tolerated, but the allergen profile is the weak point that keeps it off the #1 spot.
“Provides ~480 mg silymarin / ~180 mg silybin per serving”
The label discloses the standardized silymarin and silybin content per 2-softgel serving, and standardization to specific silybin isomers backs the number.
“Up to 3× better absorption”
The Siliphos fraction does raise silybin absorption in principle, but the specific '3×' multiplier is a manufacturer claim without a cited independent head-to-head against this exact formula.
“Standardized to silibinins and isosilybin A & B”
The label specifies standardization to defined silybin isomers rather than only total silymarin, which is a genuine formulation strength.
“Supports healthy liver function”
Dose is in the trial range, but high-quality RCTs and meta-analyses (Rambaldi 2005; Wah Kheong 2017) did not confirm a clinical benefit, so the functional claim is only partially supported.
Several liver studies dosed around 420 mg/day of silymarin; this serving clears that at ~480 mg without asking you to count out four capsules. On the 25%-weighted dose axis it's the class leader.
Only 160 mg of the load is the Siliphos phytosome; the rest is standardized extract. You get an absorption boost on part of the dose — useful, but don't read it as a fully phospholipid-complexed product like Thorne.
The softgel and phospholipid contain soy. That single fact, plus the highest per-serving price of the standardized options, is why a formula that beats #1 on dose still lands at #2.
Absorption enhancement from Siliphos is real, but the exact multiplier comes from the manufacturer. Treat it as directional, not a verified head-to-head result.
This is the pick if your goal is to hit a trial-level silymarin dose without counting out four capsules — one serving does it, and the Siliphos fraction hedges the absorption problem. The catches are real: it contains soy, it costs the most per serving of the standardized options, and the absorption multiplier is the brand's own number. For a soy-tolerant buyer who wants dose and bioavailability in one bottle, it's the strongest formulation on the page — it loses the top spot only on soy and price.
Check Life Extension on AmazonA cleaner, soy-free phytosome from a stronger QC name — at a lower per-cap dose.
See it on the list →The highest single-capsule plain-extract dose if you want a soy-free one-a-day.
See it on the list →Skip the phytosome and take two cheap standardized caps for a fraction of the cost.
See it on the list →In high-quality trials, milk thistle did not significantly influence mortality or complications of liver disease.
At 700 mg silymarin three times daily (2,100 mg/day), the primary histologic endpoint was not met, though fibrosis showed some improvement.